Ide-DNT mediated slightly but statistically significantly reduced cytotoxicity against AML cell lines, including OCI-AML3 and MV4–11, and primary AML blasts more than ctrl-DNTs in vitro (Figure S5). Here, RUNX2 is linked to acute myeloid leukemia.